Ivermectin use = steep declines in mortality

Demonstrating the complete lack of urgency with which it treats repurposed drugs, the TGA last updated its advice on ivermectin on 1 June. It claims that there is currently insufficient evidence to support its safe and effective use. Yet since 1 June results of 15 new trials and meta-analyses of ivermectin have been published almost all showing steep declines in mortality. The question that the TGA has to answer is how is it possible to approve an experimental gene therapy vaccine with plummeting efficacy, significant short-term safety signals and unknown long-term side effects and yet not recommend a drug with an outstanding safety profile, which is supported by Nobel laureates and multiple randomised controlled trials? https://www.spectator.com.au/2021/07/hunt-goes-off-script-with-ivermectin